Globe Life stock hits all-time high at 144.07 USD

Published 18/09/2025, 16:26
Globe Life stock hits all-time high at 144.07 USD

Globe Life Inc. has reached a significant milestone, with its stock hitting an all-time high of 144.07 USD. According to InvestingPro data, the company maintains a GREAT financial health score and trades at an attractive P/E ratio of 11.4x. This achievement underscores a robust performance over the past year, during which the company’s stock has experienced a notable increase of 33.83%. With a market capitalization of $11.6 billion and a year-to-date return of 28.9%, the impressive rise in stock value reflects Globe Life’s strong market position and investor confidence. The company continues to navigate the financial landscape effectively, supported by management’s aggressive share buyback program. This all-time high marks a key moment for Globe Life, highlighting its growth trajectory and potential for future success. Discover more exclusive insights and detailed analysis in Globe Life’s comprehensive Pro Research Report, available on InvestingPro.

In other recent news, Globe Life Inc. announced a dual listing on the newly launched NYSE Texas exchange while maintaining its primary listing on the New York Stock Exchange. The company also declared a quarterly dividend of $0.2700 per share, payable to shareholders on October 31, 2025. Morgan Stanley upgraded Globe Life’s stock rating to Overweight, citing the closure of investigations by the Securities and Exchange Commission and the Department of Justice, which alleviated significant uncertainties. Additionally, BMO Capital increased its price target for Globe Life to $149, highlighting the potential for the company to align more closely with its historical free cash flow and price-to-earnings metrics. The U.S. Attorney’s Office for the Western District of Pennsylvania closed its investigation into sales practices at Globe Life’s subsidiary, American Income Life, without any enforcement action. This development further reduced regulatory concerns for the company. These recent developments reflect a positive outlook from analysts and regulatory bodies.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.